- cafead   Jan 14, 2022 at 11:12: AM
via Medicare’s proposal to restrict access to a controversial Alzheimer’s drug has quickly reignited a long-simmering debate over how best to address ongoing, systemic inequities in Alzheimer’s care experienced by Black and Hispanic patients.
article source
article source